tiprankstipranks
Advertisement
Advertisement

LBRX Stock Latest News

LB Pharmaceuticals: Strong Balance Sheet, Clear Clinical Milestones Underpin Buy Rating; 12-Month $45 Price Target Reiterated
RatingsLB Pharmaceuticals: Strong Balance Sheet, Clear Clinical Milestones Underpin Buy Rating; 12-Month $45 Price Target Reiterated
12h ago
LBRX
LB Pharmaceuticals Announces $150 Million Private Placement Financing
PremiumCompany Announcements
LB Pharmaceuticals Announces $150 Million Private Placement Financing
5d ago
8K
LBRX
LB Pharmaceuticals announces $150M private placement
PremiumThe Fly
LB Pharmaceuticals announces $150M private placement
5d ago
LBRX
LB Pharmaceuticals: Buy Rating Reaffirmed on LB-102 Clinical Momentum and Regulatory Progress; $45 Price Target Maintained
PremiumRatings
LB Pharmaceuticals: Buy Rating Reaffirmed on LB-102 Clinical Momentum and Regulatory Progress; $45 Price Target Maintained
11d ago
LBRX
LB Pharmaceuticals accelerates Phase 3 schizophrenia trial timeline
PremiumCompany Announcements
LB Pharmaceuticals accelerates Phase 3 schizophrenia trial timeline
12d ago
8K
LBRX
LB Pharmaceuticals expects to report results from NOVA-2 clinical trial in 2027
PremiumThe FlyLB Pharmaceuticals expects to report results from NOVA-2 clinical trial in 2027
12d ago
LBRX
Shopify downgraded, Five Below upgraded: Wall Street’s top analyst calls
Premium
The Fly
Shopify downgraded, Five Below upgraded: Wall Street’s top analyst calls
13d ago
GS
RL
LB Pharmaceuticals initiated with an Outperform at BMO Capital
Premium
The Fly
LB Pharmaceuticals initiated with an Outperform at BMO Capital
14d ago
LBRX
LB Pharmaceuticals initiated with an Outperform at Wolfe Research
PremiumThe Fly
LB Pharmaceuticals initiated with an Outperform at Wolfe Research
27d ago
LBRX
Clear Street says Neumora failed trial does not impact LB Pharmaceuticals LB-102
PremiumThe Fly
Clear Street says Neumora failed trial does not impact LB Pharmaceuticals LB-102
2M ago
LBRX
NMRA
LB Pharmaceuticals Stockholders Approve Directors and Auditor
PremiumCompany Announcements
LB Pharmaceuticals Stockholders Approve Directors and Auditor
2M ago
8K
LBRX
Eight new option listings and one option delisting on May 28th
PremiumThe Fly
Eight new option listings and one option delisting on May 28th
2M ago
CEPT
DXYZ
LB Pharmaceuticals initiated with a Buy at Clear Street
PremiumThe FlyLB Pharmaceuticals initiated with a Buy at Clear Street
2M ago
LBRX
LB Pharmaceuticals: Buy Rating Reiterated, $45 Price Target Maintained on LB-102 Late-Stage Pipeline and Multi-Billion-Dollar Sales Potential
Premium
Ratings
LB Pharmaceuticals: Buy Rating Reiterated, $45 Price Target Maintained on LB-102 Late-Stage Pipeline and Multi-Billion-Dollar Sales Potential
2M ago
LBRX
LB Pharmaceuticals price target raised to $37 from $31 at Roth Capital
Premium
The Fly
LB Pharmaceuticals price target raised to $37 from $31 at Roth Capital
3M ago
LBRX
LB Pharmaceuticals reports Q1 EPS (67c), consensus (67c)
PremiumThe Fly
LB Pharmaceuticals reports Q1 EPS (67c), consensus (67c)
3M ago
LBRX
LB Pharmaceuticals initiated with a Buy at H.C. Wainwright
PremiumThe Fly
LB Pharmaceuticals initiated with a Buy at H.C. Wainwright
3M ago
LBRX
LB-102 Bipolar Depression Trial Moves Forward: What LBRX Investors Should Know
PremiumCompany Announcements
LB-102 Bipolar Depression Trial Moves Forward: What LBRX Investors Should Know
4M ago
LBRX
Craig-Hallum bullish on LB Pharmaceuticals, initiates with a Buy
PremiumThe Fly
Craig-Hallum bullish on LB Pharmaceuticals, initiates with a Buy
4M ago
LBRX
LB Pharmaceuticals initiated with a Buy at Craig-Hallum
PremiumThe FlyLB Pharmaceuticals initiated with a Buy at Craig-Hallum
4M ago
LBRX
LB Pharmaceuticals files to sell 4.78M shares of common stock for holders
Premium
The Fly
LB Pharmaceuticals files to sell 4.78M shares of common stock for holders
4M ago
LBRX
LB Pharmaceuticals price target raised to $40 from $35 at Stifel
Premium
The Fly
LB Pharmaceuticals price target raised to $40 from $35 at Stifel
4M ago
LBRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >